Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CCR9 | P51686 | C-C chemokine receptor type 9 (C-C CKR-9) (CC-CKR-9) (CCR-9) (G-protein coupled receptor 28) (GPR-9-6) (CD antigen CDw199) | CD markersG-protein coupled receptorsPredicted intracellular proteins | 7 | Crohn diseaseSjogren syndromeUlcerative colitis | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| CD151 | P48509 | CD151 antigen (GP27) (Membrane glycoprotein SFA-1) (Platelet-endothelial tetraspan antigen 3) (PETA-3) (Tetraspanin-24) (Tspan-24) (CD antigen CD151) | Blood group antigen proteinsCD markersDisease related genes | 4 | DeafnessEpidermolysis bullosa | Adhesion and uptake mediationImmune mediationReceptor-signaling mediation | 1 | 0.53 | ||
| CD166 | Q13740 | CD166 antigen (Activated leukocyte cell adhesion molecule) (CD antigen CD166) | Cancer-related genesCD markersPlasma proteins | 1 | Solid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||
| CD2 | P06729 | T-cell surface antigen CD2 (Erythrocyte receptor) (LFA-2) (LFA-3 receptor) (Rosette receptor) (T-cell surface antigen T11/Leu-5) (CD antigen CD2) | CD markersFDA approved drug targetsPredicted intracellular proteins | 1 | LymphomaPsoriasis | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| CD37 | P11049 | Leukocyte antigen CD37 (Tetraspanin-26) (Tspan-26) (CD antigen CD37) | CD markersPredicted intracellular proteinsPredicted membrane proteins | 4 | Diffuse large B-cell lymphomaLeukaemiaMalignant haematopoietic neoplasm | Clinical-translation mediation | 1 | 0.53 | ||
| CD40L | P29965 | CD40 ligand (CD40-L) (T-cell antigen Gp39) (TNF-related activation protein) (TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form (sCD40L)] | Cancer-related genesCandidate cardiovascular disease genesCD markers | 1 | B-cell lymphomaDiabetes mellitusDiffuse large B-cell lymphoma | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||
| CD79B | P40259 | B-cell antigen receptor complex-associated protein beta chain (B-cell-specific glycoprotein B29) (Ig-beta) (Immunoglobulin-associated B29 protein) (CD antigen CD79b) | Cancer-related genesCD markersDisease related genes | 1 | Autoimmune diseaseDiffuse large B-cell lymphomaFollicular lymphoma | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| CD80 | P33681 | T-lymphocyte activation antigen CD80 (Activation B7-1 antigen) (BB1) (CTLA-4 counter-receptor B7.1) (B7) (CD antigen CD80) | CD markersFDA approved drug targetsPredicted intracellular proteins | 1 | Diabetes mellitusLung cancerLymphoma | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||
| CDK5 | Q00535 | Cyclin-dependent kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Cyclin-dependent-like kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) | Disease related genesEnzymesHuman disease related genes | LissencephalyObesity | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | |||
| CDON | Q4KMG0 | Cell adhesion molecule-related/down-regulated by oncogenes | Disease related genesHuman disease related genesPredicted membrane proteins | 1 | Holoprosencephaly | Receptor-signaling mediation | 1 | 0.53 |